AXichem AB Financials
| AXIC-A Stock | SEK 1.26 0.04 3.28% |
AXichem |
Understanding current and past AXichem AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AXichem AB's financial statements are interrelated, with each one affecting the others. For example, an increase in AXichem AB's assets may result in an increase in income on the income statement.
Please note, the presentation of AXichem AB's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AXichem AB's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AXichem AB's management manipulating its earnings.
AXichem AB Stock Summary
AXichem AB competes with Enzymatica Publ, Bactiguard Holding, Cantargia, BIMobject, and Alzinova. aXichem AB develops, patents, and markets natural-analogue industrial compounds for the marine, pest control, feed ingredient, and medical application markets in Sweden and internationally. It offers aXiphen-repellent, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables aXiphen-feed ingredient for pig and poultry diets and aXiphen for use in various foods and dietary supplements, as well as in the pharmaceutical industry. aXichem AB is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0005250719 |
| Business Address | SOedergatan 26, Malm, |
| Sector | Basic Materials |
| Industry | Chemicals |
| Benchmark | Dow Jones Industrial |
| Website | www.axichem.com |
| Phone | 46 4 67 80 06 73 |
| Currency | SEK - Swedish Kronor |
You should never invest in AXichem AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AXichem Stock, because this is throwing your money away. Analyzing the key information contained in AXichem AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AXichem AB Key Financial Ratios
AXichem AB's financial ratios allow both analysts and investors to convert raw data from AXichem AB's financial statements into concise, actionable information that can be used to evaluate the performance of AXichem AB over time and compare it to other companies across industries.| Return On Equity | -0.36 | |||
| Return On Asset | -0.17 | |||
| Target Price | 57.0 | |||
| Beta | 0.36 |
AXichem Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AXichem AB's current stock value. Our valuation model uses many indicators to compare AXichem AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AXichem AB competition to find correlations between indicators driving AXichem AB's intrinsic value. More Info.aXichem AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AXichem AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AXichem AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.aXichem AB Systematic Risk
AXichem AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AXichem AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on aXichem AB correlated with the market. If Beta is less than 0 AXichem AB generally moves in the opposite direction as compared to the market. If AXichem AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one aXichem AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AXichem AB is generally in the same direction as the market. If Beta > 1 AXichem AB moves generally in the same direction as, but more than the movement of the benchmark.
AXichem AB December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AXichem AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of aXichem AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of aXichem AB based on widely used predictive technical indicators. In general, we focus on analyzing AXichem Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AXichem AB's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.9 | |||
| Information Ratio | 0.0087 | |||
| Maximum Drawdown | 35.65 | |||
| Value At Risk | (8.53) | |||
| Potential Upside | 12.4 |
Complementary Tools for AXichem Stock analysis
When running AXichem AB's price analysis, check to measure AXichem AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AXichem AB is operating at the current time. Most of AXichem AB's value examination focuses on studying past and present price action to predict the probability of AXichem AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AXichem AB's price. Additionally, you may evaluate how the addition of AXichem AB to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |